高级搜索
低剂量粒生素对恶性肿瘤化疗所致白细胞减少的临床疗效观察[J]. 肿瘤防治研究, 2001, 28(04): 306-307. DOI: 10.3971/j.issn.1000-8578.1380
引用本文: 低剂量粒生素对恶性肿瘤化疗所致白细胞减少的临床疗效观察[J]. 肿瘤防治研究, 2001, 28(04): 306-307. DOI: 10.3971/j.issn.1000-8578.1380
Observation of using low-dose Lishengsu for the Leukocyte reducing in Malignant Tumor Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2001, 28(04): 306-307. DOI: 10.3971/j.issn.1000-8578.1380
Citation: Observation of using low-dose Lishengsu for the Leukocyte reducing in Malignant Tumor Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2001, 28(04): 306-307. DOI: 10.3971/j.issn.1000-8578.1380

低剂量粒生素对恶性肿瘤化疗所致白细胞减少的临床疗效观察

Observation of using low-dose Lishengsu for the Leukocyte reducing in Malignant Tumor Chemotherapy

  • 摘要: 目的 评价低剂量粒生素对恶性肿瘤化疗所致白细胞减少的疗效。方法 采用每天皮下注射粒生素 75μg一次治疗 45例因恶性肿瘤化疗所致白细胞减少的患者, 他们治疗前外周血白细胞总数平均值为 ( 1 .85± 2 .66)× 1 0 9/ L。结果  45例患者治疗后外周血白细胞总数上升达显效( 1 8例 )或有效 ( 2 4例 )所需时间为 5.5± 4.8d,有效率 93.33% ;无效 3例, 占 6.67%。结论 每天皮下注射低剂量粒生素 ( 75μg/ d,可以明显减轻化疗过程中外周血白细胞下降程度、缩短白细胞在4.0× 1 0 9/ L以下的持续时间及恢复到 4.0× 1 0 9/ L以上的时间, 且毒副反应轻微、安全可靠、费用较低, 值得临床推广应用.

     

    Abstract: Objective To appraise the curative effect of using low dose lishengsu for the leukocyte reducing in malignant tumor chemotherapy. Methods The rhG CSF(Lishegsu) at a dose of 75μg/body•day was given subcataneously for forty five patients with the leukocyte reducing in malignant tumor chemotherapy,and their average leukocyte count were(1.85±2.66)×10 9/L before receiving the treatment. Results The time of fory five patients s circum leukocyte count upawing to availability(18 cases)or producing effects,was...

     

/

返回文章
返回